Checkpoint Therapeutics Inc [CKPT] stock is trading at $3.30, down -3.79%. An important factor to consider is whether the stock is rising or falling in short-term value. The CKPT shares have gain 3.45% over the last week, with a monthly amount glided 9.63%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, B. Riley Securities started tracking the stock with Buy rating on June 09, 2021, and set its price target to $18. On January 20, 2021, Cantor Fitzgerald initiated with a Overweight rating and assigned a price target of $16 on the stock. Lake Street started tracking the stock assigning a Buy rating. H.C. Wainwright initiated its recommendation with a Buy and recommended $11 as its price target on December 08, 2017.
Checkpoint Therapeutics Inc [CKPT] stock has fluctuated between $1.36 and $3.97 over the past year. Checkpoint Therapeutics Inc [NASDAQ: CKPT] shares were valued at $3.30 at the most recent close of the market.
Analyzing the CKPT fundamentals
Checkpoint Therapeutics Inc [NASDAQ:CKPT] reported sales of 0.05M for the trailing twelve months, which represents a drop of -100.00%. Gross Profit Margin for this corporation currently stands at -451.68% with Operating Profit Margin at -798.17%, Pretax Profit Margin comes in at -988.68%, and Net Profit Margin reading is -988.68%. To continue investigating profitability, this company’s Return on Assets is posted at -8.97, Equity is 3.6 and Total Capital is 2.98.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.21 points at the first support level, and at 3.12 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.43, and for the 2nd resistance point, it is at 3.56.
Ratios To Look Out For
For context, Checkpoint Therapeutics Inc’s Current Ratio is 0.29. On the other hand, the Quick Ratio is 0.29, and the Cash Ratio is 0.26. Considering the valuation of this stock, the price to sales ratio is 2924.60.
Transactions by insiders
Recent insider trading involved Oliviero James F III, CEO, President and Director, that happened on Jun 26 ’24 when 24610.0 shares were sold. Chief Financial Officer, GRAY WILLIAM GARRETT completed a deal on Jun 26 ’24 to sell 13038.0 shares. Meanwhile, CEO, President and Director Oliviero James F III sold 5894.0 shares on Feb 28 ’24.
